Manufacturing.pharmaceutical-business-review.com

Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs such as Medicare and Medicaid, to cover the costs. That isn’t an...

Source: Blogs Barrons Stocks To Watch Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) were found to have infringed on patents held by Amgen (AMGN) involving a new type of cholesterol drug. Evercore ISI’s Mark Schoenebaum has the details: We understand...

Big pharmaceutical companies like Amgen (NASDAQ:AMGN), Sanofi (NYSE:SNY) and Regeneron Pharmaceuticals (NASDAQ:REGN) are achieving major breakthroughs backed by genetics research. As these drug companies come to rely more and more heavily on genomics...

Thu Jan 23, 2014 12:57pm EST <span id="articleText"> <span id="midArticle_0"/>By Bill Berkrot <span id="midArticle_1"/>Jan 23 (Reuters) - A cholesterol fighter developed by Amgen Inc from a highly promising new class of medicines...

From Ian: The hateful whispers that make me want to move from London to Tel Aviv There’s a train of thought among right-thinking people in London at the moment that Israel is culpable; that it is responsible for all the ills of the Palestinians, all...